Impact of repeated nasal sampling on detection and quantification of SARS-CoV-2
Abstract The impact of repeated sample collection on COVID-19 test performance is unknown. The FDA and CDC currently recommend the primary collection of diagnostic samples to minimize the perceived risk of false-negative findings. We therefore evaluated the association between repeated sample collec...
Guardado en:
Autores principales: | Joshua M. Levy, Jennifer K. Frediani, Erika A. Tyburski, Anna Wood, Janet Figueroa, Russell R. Kempker, Paulina A. Rebolledo, Mark D. Gonzalez, Julie Sullivan, Miriam B. Vos, Jared O’Neal, Greg S. Martin, Wilbur A. Lam, Jesse J. Waggoner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/39dfb0e9ecc74fe6a6c372c4079c88bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration
por: Jennifer K. Frediani, et al.
Publicado: (2021) -
In Vitro Ciliotoxicity and Cytotoxicity Testing of Repeated Chronic Exposure to Topical Nasal Formulations for Safety Studies
por: Larisa Tratnjek, et al.
Publicado: (2021) -
Automated quantification of bioluminescence images
por: Alexander D. Klose, et al.
Publicado: (2018) -
Pilomatrixoma nasal: Nasal pilomatricoma
por: Inzunza P,Fernando, et al.
Publicado: (2009) -
The British Virgin Islands national integrated development strategy
por: O'Neal, Otto
Publicado: (2014)